Institutional investors purchased a net $3.1 million shares of CPHD during the quarter ended December 2013 and now own 105.72% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RIVERBRIDGE PARTNERS LLC Bought 1.3 Million shares of Cepheid
LORD, ABBETT & CO. LLC Bought 1.1 Million shares of Cepheid